Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA)
Circulation · 2024
DOI: 10.1161/circulationaha.123.065520 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, 2024. Verfasst von Katsumi Miyauchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan (K.M., H.I., Y.N., H.D.). Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary Artery Disease, Secondary Prevention. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Low plasma levels of eicosapentaenoic acid (EPA) are associated with cardiovascular events. This trial aimed to assess the clinical benefits of icosapent ethyl in patients with coronary artery disease, a low EPA/arachidonic acid (AA) ratio, and statin treatment. METHODS: In this prospective, multicenter, randomized, open-label, blinded end-point study, patients with stable coronary artery disease and a low EPA/AA ratio (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan (K.M., H.I., Y.N., H.D.).
- Japan Red Cross Society, Nasu Red Cross Hospital, Otawara, Tochigi, Japan (T.I.).
- Dokkyo Medical University, Mibu, Tochigi, Japan (T.I.).
- Osaka Anti-Tuberculosis Association, Osaka Fukujyuji Hospital, Neyagawa, Osaka, Japan (A.H.).
- Department of Cardiology, Yokohama City University Medical Center, Kanagawa, Japan (K.K.).
- Department of Cardiology, Fujita Health University, Toyoake, Aichi, Japan (Y.O.).
ORCID-Profile: Katsumi Miyauchi, Yuji Nishizaki, Kazuo Kimura, Yukio Ozaki, Toyoaki Murohara, Sachiko Tanaka-Mizuno, Naotake Yanagisawa, Tosiya Sato, Hiroyuki Daida
Zitieren
APA
Miyauchi, K., Iwata, H., Nishizaki, Y., Inoue, T., Hirayama, A., Kimura, K., Ozaki, Y., Murohara, T., Ueshima, K., Kuwabara, Y., Tanaka-Mizuno, S., Yanagisawa, N., Sato, T., Daida, H., & RESPECT-EPA Investigators (2024). Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation. https://doi.org/10.1161/circulationaha.123.065520
Vancouver
Miyauchi K, Iwata H, Nishizaki Y, Inoue T, Hirayama A, Kimura K, et al. Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation. 2024. doi:10.1161/circulationaha.123.065520
BibTeX
@article{Miyauchi2024,
author = {Miyauchi, Katsumi and Iwata, Hiroshi and Nishizaki, Yuji and Inoue, Teruo and Hirayama, Atsushi and Kimura, Kazuo and Ozaki, Yukio and Murohara, Toyoaki and Ueshima, Kenji and Kuwabara, Yoshihiro and Tanaka-Mizuno, Sachiko and Yanagisawa, Naotake and Sato, Tosiya and Daida, Hiroyuki and RESPECT-EPA Investigators, RESPECT-EPA Investigators},
title = {Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA)},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.065520}
}
EUVIMED